Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026)
Neumora Therapeutics' quarterly Tax Provisions came in at $30000.0 in Q1 2026, down 71.43% year-on-year from $105000.0 in Q1 2025, and up 20.0% quarter-over-quarter from $25000.0 in Q2 2025.
Neumora Therapeutics has reported Tax Provisions for 3 years, with the latest figure at $30000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 71.43% year-over-year to $30000.0; the trailing twelve-month figure through Mar 2026 stood at $55000.0 (down 80.57% YoY), and the FY2025 full-year result was $130000.0, down 26.97% from the prior year.
- Tax Provisions for Q1 2026 stood at $30000.0, up from $25000.0 in the prior quarter.
- The five-year high for Tax Provisions was $125000.0 in Q2 2024, with the low at $25000.0 in Q2 2025.
- Average Tax Provisions over 3 years is $67600.0, with a median of $53000.0 recorded in 2024.
- Year-over-year, Tax Provisions slumped 80.0% in 2025 and plunged 71.43% in 2026.
- Tracing NMRA's Tax Provisions over 3 years: stood at $53000.0 in 2024, then tumbled by 52.83% to $25000.0 in 2025, then advanced by 20.0% to $30000.0 in 2026.
- The last three Tax Provisions figures came in at $30000.0 (Q1 2026), $25000.0 (Q2 2025), and $105000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Neumora Therapeutics | 328.27 Mn | 328.27 Mn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 125,000.00 |